Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Molecular Devices ChinaMolecular Devices China
VS
GenentechGenentech
Molecular Devices China

Molecular Devices China

长宁区福泉北路, 上海, 200335, CN

Last Update: 01/12/2025

View Profile
751/1000Fair

Molecular Devices始创于上世纪80年代美国硅谷,作为全球高通量仪器设备的优秀品牌,一直致力于为生命科学研究及药物研发提供先进的解决方案。其产品覆盖微孔板检测分析、高通量筛选、高内涵成像、高效克隆筛选等。公司以持续创新、快速高效、高质量的产品及完善的售后服务著称业内。 Molecular Devices为您提供高性能的分析检测系统,加快和改进药物研发及基础生命科学的研究。我们的产品除了用于科研单位和部门外,还帮助制药和生物技术企业从分子、细胞和系统水平去了解各项生物功能,研究开发新的治疗方法。 Molecular Dev...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
Genentech

Genentech

1 Dna Way, South San Francisco, California, US, 94080

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.gene.com
794/1000Fair

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a differe...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:18,082
Subsidiaries:50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Molecular Devices China

Molecular Devices China

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Genentech

Genentech

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Molecular Devices China in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Genentech in 2026.

Incidents

Incident History - Molecular Devices China (X = Date, Y = Severity)

Molecular Devices China cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Genentech (X = Date, Y = Severity)

Genentech cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Molecular Devices China

Molecular Devices China

Incidents
No explicit notable incidents reported.
Genentech

Genentech

Incidents
No explicit notable incidents reported.

FAQ

Between Molecular Devices China company and Genentech company, which one has the best AI Cybersecurity Score ?
Between Molecular Devices China company and Genentech company, which one has experienced more cyber incidents in the past ?
Between Molecular Devices China company and Genentech company, which one has experienced more cyber incidents this year ?
Between Molecular Devices China company and Genentech company, which one has experienced at least one ransomware attack ?
Between Molecular Devices China company and Genentech company, which one has experienced at least one data breach ?
Between Molecular Devices China company and Genentech company, which one has experienced at least one targeted cyberattack ?
Between Molecular Devices China company and Genentech company, which one has experienced at least one vulnerability ?
Between Molecular Devices China company and Genentech company, which one holds the most compliance certifications ?
Between Molecular Devices China company and Genentech company, which one holds the fewest compliance certifications ?
Between Molecular Devices China company and Genentech company, which one has the most subsidiaries ?
Between Molecular Devices China company and Genentech company, which one has the largest number of employees ?
Between Molecular Devices China and Genentech, which company holds both SOC 2 Type 1 certifications ?
Between Molecular Devices China and Genentech, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Molecular Devices China or Genentech ?
Which company is PCI DSS compliant - Molecular Devices China or Genentech ?
Between Molecular Devices China and Genentech, which company complies with HIPAA regulations for healthcare data ?
Between Molecular Devices China and Genentech, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-16174
SUMMARY

Netskope was notified about a potential gap in Netskope Endpoint DLP (EPDLP) running on Windows systems. Successful exploitation of the gap could potentially allow a privileged user to send a crafted message to the EPDLP process port to trigger an integer overflow, leading to memory corruption. Successful exploitation would require the EPDLP module to be enabled in the client configuration, and that Memory Integrity is disabled. A successful exploit could potentially result in a denial-of-service, arbitrary code execution, or privilege escalation on the local machine.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: )
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:P/PR:H/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-16172
SUMMARY

Netskope was notified of an out-of-bounds heap read affecting the Endpoint DLP (EPDLP) service of the Netskope Client. A local standard user could potentially send a specially crafted message that is not properly validated with a bounds check, likely crashing the kernel driver handler. Successful exploitation could potentially crash the EPDLP service, temporarily interrupting DLP enforcement. A successful exploit could potentially also reveal per-boot memory layout information to unauthorized users.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.0
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-87958
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 is vulnerable to a denial of service where a specific functionality on a Db2 server can be disabled by a privileged user under certain conditions.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86093
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an attacker with the ability to control or impersonate a DRDA server endpoint to execute arbitrary commands on Db2 clients due to a stack-based buffer overflow that improperly copies user-controlled data into a fixed-size stack buffer without bounds checking.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.6
CVE-2026-86087
SUMMARY

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 could allow an authenticated user to send a specially crafted request to write arbitrary files on the system.

PUBLISHED
Date2026-09-10
UPDATED
Date2026-09-10
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8